The prevalence of gastroesophageal reflux disease and laryngopharyngeal reflux in patients with dysphagia after radiotherapy for nasopharyngeal carcinoma
Head & Neck · 2024
DOI: 10.1002/hed.27645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2024. Verfasst von Peter K M Ku und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology - Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China. Hauptthemen laut MEDLINE: Laryngopharyngeal Reflux, Gastroesophageal Reflux, Deglutition Disorders, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Dysphagie
Abstract (Originalsprache)
Background
The prevalence of gastroesophageal reflux disease (GERD) and laryngopharyngeal reflux (LPR) in post‐irradiated patients with nasopharyngeal carcinoma (NPC) is unknown. Materials and methods In a cross‐sectional study, 31 NPC and 12 control patients completed questionnaires for GERD/LPR before esophageal manometry and 24‐h pH monitoring. The DeMeester score and reflux finding score (RFS) were used to define GERD and LPR, respectively. Risk factors were identified.
Results
51.6% of NPC and 8.3% of control patients, and 77.4% of NPC and 33% of control patients, were GERD‐positive and LPR‐positive, respectively. The GERD/LPR questionnaire failed to identify either condition in patients with NPC. No parameter differences in esophageal manometry or pneumonia incidence were noted between GERD/LPR‐positive and GERD/LPR‐negative patients. Post radiotherapy duration, high BMI, lack of chemotherapy, and dysphagia were positive risk factors for GERD/LPR.
Conclusions
A high prevalence of GERD/LPR in patients with post‐irradiated NPC exists, but reflux symptoms are inadequate for diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology - Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China.
- Department of Otorhinolaryngology - Head and Neck Surgery, United Christian Hospital and Tseung Kwan O Hospital, Hong Kong, China.
- Department of Gastroenterology and Hepatology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China.
- Department of Speech Therapy, Prince of Wales Hospital, Hong Kong, China.
- Department of Clinical Oncology and Radiotherapy, Prince of Wales Hospital, Hong Kong, China.
- Department of Oncology, Queen Elizabeth Hospital, Hong Kong, China.
ORCID-Profile: Peter K M Ku, Ryan H W Cho, Alex K F Lee
Zitieren
APA
Ku, P. K. M., Vlantis, A. C., Hui, T. S. C., Yeung, Z. W. C., Cho, R. H. W., Wong, M. H. K., Lee, A. K. F., Yeung, D. C. M., Chan, S. Y. P., Chan, B. Y. T., Chang, W. T., Mok, F., Wong, K. H., Wong, J. K. T., Abdullah, V., van Hasselt, A., Wu, J. C. Y., & Tong, M. C. F. (2024). The prevalence of gastroesophageal reflux disease and laryngopharyngeal reflux in patients with dysphagia after radiotherapy for nasopharyngeal carcinoma. Head & Neck. https://doi.org/10.1002/hed.27645
Vancouver
Ku PKM, Vlantis AC, Hui TSC, Yeung ZWC, Cho RHW, Wong MHK, et al. The prevalence of gastroesophageal reflux disease and laryngopharyngeal reflux in patients with dysphagia after radiotherapy for nasopharyngeal carcinoma. Head & Neck. 2024. doi:10.1002/hed.27645
BibTeX
@article{Ku2024,
author = {Ku, Peter K M and Vlantis, Alexander C and Hui, Thomas S C and Yeung, Zenon W C and Cho, Ryan H W and Wong, Marc H K and Lee, Alex K F and Yeung, David C M and Chan, Simon Y P and Chan, Becky Y T and Chang, Wai-Tsz and Mok, Florence and Wong, Kam-Hung and Wong, Jeffrey K T and Abdullah, Victor and van Hasselt, Andrew and Wu, Justin C Y and Tong, Michael C F},
title = {The prevalence of gastroesophageal reflux disease and laryngopharyngeal reflux in patients with dysphagia after radiotherapy for nasopharyngeal carcinoma},
journal = {Head & Neck},
year = {2024},
doi = {10.1002/hed.27645}
}
EUVIMED